FMP
BINEX Co., Ltd.
053030.KQ
KOE
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd. has a co-development partnership with Genexine, Inc. to develop COVID-19 vaccine. The company was founded in 1957 and is based in Incheon, South Korea.
15550 KRW
200 (1.29%)
Valuation Date:
Mar 21, 2025 2:30 AM
Share Price on Valuation Date
$15.55k
Stock Beta
0.72412753
Shares Outstanding
31847688